-
Apaolaza PS, del Pozo-Rodríguez A, Torrecilla J, Rodríguez-Gascón A, Rodríguez JM, Friedrich U, Weber BHF, Solinís MA
Solid Lipid Nanoparticle-based vectors intended for the treatment of X-linked juvenile retinoschisis by gene therapy: In vivo approaches in Rs1h-deficient mouse model
Journal of Controlled Release,
2015;
217,
273 - 283
-
Lertxundi U, Isla A, Solinís MA, Domingo-Echaburu S, García M, Aguirre C, García-Moncó JC
Adverse Reactions to Antipsychotics in Parkinson Disease: An Analysis of the Spanish Pharmacovigilance Database
Clinical Neuropharmacology,
2015;
38,
69 - 84
-
Lertxundi U, Isla A, Solinís MA, Domingo-Echaburu S, Hernandez R, García-Moncó JC
A Proposal to Prevent Omissions and Delays of Antiparkinsonian Drug Administration in Hospitals
The Neurohospitalist,
2015;
5,
53 - 54
-
Lertxundi U, Isla A, Solinis MA, Domingo-Echaburu S, Hernandez R, Peral-Aguirregoitia J, Medrano J
Anticholinergic burden in Parkinson's disease inpatients
European Journal of Clinical Pharmacology,
2015;
71,
1271 - 1277
-
Rodríguez-Gascón A, del Pozo-Rodríguez A, Isla Ruiz A, Solinís Aspiazu MA
Vaginal gene therapy
Advanced Drug Delivery Reviews,
2015;
92,
71 - 83
-
Asín-Prieto E, Soraluce A, Trocóniz IF, Campo E, Sáez de Ugarte J, Rodriguez-Gascón A, Isla A
Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: Model-based evaluation of standard dosing regimens
International Journal of Antimicrobial Agents,
2015;
45,
504 - 511
-
Asín-Prieto E, Rodríguez-Gascón A, Isla A
Applications of the Pharmacokinetic/Pharmacodynamic (PK/PD) Analysis of Antimicrobial Agents
Journal of Infection and Chemotherapy,
2015;
21,
319 - 329
-
Canut A, Isla A, Rodríguez-Gascón A
Pharmacokinetic/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skin-structure infections in patients with normal and impaired renal function
International Journal of Antimicrobial Agents,
2015;
45,
399 - 405
-
Otaegui D, Masdeu C, Aldaba E, Vara Y, Zubia A, San Sebastián E, Alcalá M, Villafruela S, Cossío FP, Rodríguez-Gascón A
Development and validation of a LC-MS assay for the quantification of IKH12 a novel anti-tumor candidate in rat plasma and tissues and its application in a pharmacokinetic study
Biomedical Chromatography,
2015;
29,
1249 - 1258
-
Canut A, Aguilar L, Cobo J, Giménez MJ, Rodríguez-Gascón A
Análisis farmacocinético-farmacodinámico en microbiología: herramienta para evaluar el tratamiento antimicrobiano
Enfermedades infecciosas y microbiología clínica,
2015;
33,
48 - 57
-
Torrecilla J, del Pozo-Rodríguez A, Apaolaza PS, Solinís MA, Rodríguez-Gascón A
Solid lipid nanoparticles as non-viral vector for the treatment of chronic hepatitix C by RNA interference
International Journal of Pharmaceutics,
2015;
479,
181 - 188
-
Solinís MA, del Pozo-Rodríguez A, Apaolaza PS, Rodríguez-Gascón A
Treatment of ocular disorders by gene therapy
European Journal of Pharmaceutics and Biopharmaceutics,
2015;
95,
331 - 342
-
Ruiz de Garibay A, Solinís MA, del Pozo-Rodríguez A, Apaolaza PS, Shen JS, Rodríguez-Gascón A
Solid lipid nanoparticles as non-viral vectors for gene transfection in a cell model of Fabry disease
Journal of Biomedical Nanotechnology,
2015;
11,
500 - 511
